Executive Summary
The U.S. Durable Medical Equipment (DME) market is undergoing rapid transformation. Market revenues have grown from $60 billion in 2020 to $85 billion in 2024 and are projected to exceed $110 billion by 2028. Key drivers include demographic shifts, payer alignment, and innovations in device technology. Consolidation has accelerated, with quarterly deal volume climbing to nine transactions by Q2 2025. For operators and investors, the sector offers predictable recurring revenues, operational synergy opportunities, and strategic positioning for the ongoing shift to home-based care.
1. Market Growth and Outlook
The DME market has expanded steadily over the past five years, fueled by an aging population, payer support for home care, and innovative technologies. According to MedPAC and CMS projections, the market will likely reach $110–115 billion by 2028. The chart below illustrates historical and projected growth.
Figure 1: U.S. DME Market Size Growth (2020–2028). Source: MedPAC, CMS.
2. Market Composition
The DME market is diversified across multiple subsectors. Respiratory and sleep devices represent approximately 35% of revenue, followed by mobility and complex rehab technology (25%), diabetes and chronic care solutions (20%), enteral and wound care (15%), and orthotics and prosthetics (5%). This diversity provides revenue stability and resilience against market fluctuations.
Figure 2: U.S. DME Revenue by Subsector (2024 Estimate). Source: CMS, AAHomecare.
3. Key Players and Market Share
The DME industry remains fragmented, but consolidation has given certain players significant market share. Owens & Minor, through its Patient Direct division, leads with around 30% share. Lincare, AdaptHealth, Viemed, and Quipt collectively hold another 30% of the market. Niche leaders like Numotion, NSM, and Hanger dominate complex rehab technology and orthotics/prosthetics. The chart below highlights relative market share.
Figure 3: Market Share by Major DME Platforms (2024 Estimate). Source: Public Filings, Investor Presentations.
4. M&A Activity
M&A activity has surged as operators pursue scale and efficiency. From one or two deals per quarter in early 2023, activity ramped to nearly nine transactions per quarter by mid-2025. Key drivers include fragmentation, recurring revenue streams, favorable demographics, and operational synergies. The chart below illustrates quarterly deal volume trends.
Figure 4: DME M&A Deal Count per Quarter (2023 Q1 – 2025 Q2). Source: PitchBook, CapitalIQ, Industry Reports.
5. Strategic Takeaways
– Scale matters: Operators that consolidate will gain leverage with suppliers and payers.
– Compliance is critical: Increased scrutiny demands robust governance and documentation.
– Invest in technology: Integrated platforms and remote monitoring will differentiate leaders.
– Focus on patient experience: Retention and satisfaction will drive recurring revenue growth.
– Prepare for policy shifts: Competitive bidding updates and reimbursement changes will affect margins.